Digital Health
ConcertAI’s TeraRecon Integrates AI-based Chest Solutions into Eureka Clinical AI Platform through Riverain Technologies Partnership
ConcertAI’s TeraRecon Eureka Clinical AI SaaS platform brings artificial intelligence (AI) and Deep Learning technologies to automate thoracic image…
ConcertAI’s TeraRecon Eureka Clinical AI SaaS platform brings artificial intelligence (AI) and Deep Learning technologies to automate thoracic image interpretation for improved accuracy and accelerated interpretation. This provides a comprehensive AI solution for multi-specialty care teams that improves patient care.
Riverain Technologies, the pioneer of Clear Visual Intelligence (CVI) for chest imaging interpretation provides its unique imaging interpretation solution, ClearRead CT. With ClearRead CT, patients’ care will now include CVI with vessel suppression for chest imaging interpretation alongside standard CT images for interpretation. Improving diagnostic accuracy and earlier intervention for better patient outcomes, ClearRead CT with CVI has shown a 29% reduction in missed nodules and a 26% reduction in nodule search time.
Recommended AI News: T-Mobile Magenta Drive for BMW Powers America’s First 5G Connected Cars
“We are excited about the new addition to our growing platform as it will further enable us to offer one point of access to a crucial assembly of clinically proven AI solutions, all delivered in a streamlined manner into existing physician workflows,” said Dan McSweeney, President of Terarecon.
“At Riverain, we deliver technology that transforms futures – our customers trust and value our robust chest health solutions focused on early disease and nodule detection. We are thrilled to be a part of the TeraRecon AI partner ecosystem and to offer our solutions on the Eureka Clinical AI Platform and to all healthcare providers needing these services in a streamlined and best-in-breed ecosystem that TeraRecon offers,” said Steve Worrell, Chief Executive Officer at Riverain Technologies.
Recommended AI News: Mavenir Announces Business Communications Portfolio
Eureka Clinical AI is the leading AI SaaS imaging interpretation and Clinical Decision Augmentation solution from ConcertAI’s TeraRecon. As the industry’s most broadly deployed platform it is unique in being open to 3rd party AI algorithms allowing consolidated management of all AI interpretation solutions with seamless PACS integrations. Eureka Clinical AI allows clinicians to directly interact with the AI to ensure accurate and holistic algorithm training. Multi-specialty care teams can see results and receive mobile alerts to confirm AI findings, ensuring optimal and timely patient interventions, management and coordinated care delivery.
Recommended AI News: Titaniam Announces Completion of Product Suite to Push Back on the Ransomware Problem
[To share your insights with us, please write to sghosh@martechseries.com]
The post ConcertAI’s TeraRecon Integrates AI-based Chest Solutions into Eureka Clinical AI Platform through Riverain Technologies Partnership appeared first on AiThority.
Keep it Short
By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
Seattle startup Olamedi building platform to automate health clinic communications
A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…
